Travanti Pharma Inc - The Innovative Drug Delivery Companyhome
corporate profiletechnology platformscommercial productsscientific & clinicalcontact the company
border


Selected Bibliography

Basic Studies

Anderson CR, Boeh SD, Morris RL, Panus PC, Sembrowich WL. Intracutaneous and transcutaneous drug penetration following high and low current iontophoresis (PO-RR-22-TH). Abstract of paper accepted for presentation at PT 2002: The Annual Conference and Exposition of the APTA, June 5-8, 2002.

Anderson CR, Boeh SD, Morris RL, Panus PC, Sembrowich WL. Quantification of total dexamethasone-phosphate delivery by iontophoresis (PL-RR-155-F). Abstract of paper accepted for presentation at PT 2002: The Annual Conference and Exposition of the APTA, June 5-8, 2002.

Banga, A.K. and P.C.Panus. Clinical Applications of Iontophoretic Devices in Rehabilitation Medicine. Critical Reviews in Physical and Rehab. Med.. 10:147-179, 1998.

Costello, C.T., and A.H. Jeske. Iontophoresis: applications in transdermal medication delivery. Phys. Ther. 75:554-63, 1995.

Glass, J.M., R.L.Stephen, and S.C. Jacobson. The quantity and distribution of radiolabeled dexamethasone delivered to tissue by iontophoresis. Int. J. Derm. 19:519-25, 1980.

Harris, P.R. Iontophoresis: clinical research in musculoskeletal inflammatory conditions. J. Orthop. Sports. Phys. Ther. 4:109-12 , 1982.

Li, L.C., and R.A. Scudds. Iontophoresis: an overview of the mechanisms and clinical application. Arthritis. Care. Res. 8:51-61, 1995.

Riviere, J.E., N.A. Monteiro-Riviere, and A.O. Inman. Determination of lidocaine concentrations in skin after transdermal iontophoresis: effects of vasoactive drugs. Pharm. Res. 9:211-4, 1992.

Roberts, M.S. Targeted drug delivery to the skin and deeper tissues: role of physiology, solute structure and disease. Clin. Exp. Pharmacol. Physiol. 24:874-9, 1997.

Singh, P., M. Anliker, G.A.Smith, D. Zavortink, and H.I. Maibach. Transdermal iontophoresis and solute penetration across excised human skin. J Pharm Sci. 84:1342-6, 1995.

Singh, P., and M.S. Roberts. Iontophoretic transdermal delivery of salicylic acid and lidocaine to local subcutaneous structures. J. Pharm. Sci. 82:127-31, 1993.

Singh, P., and M.S. Roberts. Effects of vasoconstriction on dermal pharmacokinetics and local tissue distribution of compounds. J. Pharm. Sci. 83: 783-91, 1994.

Varvel, J.R., S.L. Shafer, S.S. Hwang, P.A.Coen, and D.R. Stanski. Absorption characteristics of transdermally administered fentanyl. Anesthesiology. 70:928-34, 1989.


Clinical Studies

Banta, C.A. A prospective, nonrandomized study of iontophoresis, wrist splinting, and antiinflammatory medication in the treatment of early-mild carpal tunnel syndrome. J. Occup. Med . 36:166-8, 1994.

Bertolucci, L.E. Introduction of antiinflammatory drugs by iontophoresis: double blind study. J. Orthop. Sports. Phys. Ther. 4:103-8 , 1982.

Demirtas, R.N., and C.,Oner. The treatment of lateral epicondylitis by iontophoresis of sodium salicylate and sodium diclofenac. Clin Rehabil. 12:23-9, 1998.

Gudeman, S.D., S.A. Eisele, R.S. Heidt Jr., A.J.Colosimo, and A.L.Stroupe. Treatment of plantar fasciitis by iontophoresis of 0.4% dexamethasone: A randomized, double-blind, placebo-controlled study. Am. J. Sports. Med. 25:312-6, 1997.

Harris, P.R. Iontophoresis: clinical research in musculoskeletal inflammatory conditions. J. Orthop. Sports. Phys. Ther. 4:109-12 , 1982.

Hasson, S.H., G.H.Henderson, J.C.Daniels, and D.A. Schieb. Exercise training and dexamethasone iontophoresis in rheumatoid arthritis: a case study. Physiother. Can. 43:11-4, 1991.

Japour, C.J., R. Vohra, P.K.Vohra, L. Garfunkel, and N. Chin. Management of heel pain syndrome with acetic acid iontophoresis. J Am Podiatr Med Assoc. 89:251-7, 1999.

Li, L.C., R.A. Scudds, C.S. Heck, and M. Harth. The efficacy of dexamethasone iontophoresis for the treatment of rheumatoid arthritic knees: a pilot study. Arthritis. Care. Res. 9:126-32, 1996.



  home      Rev 1 Copyright © 2002, Travanti Pharma Inc. 1-866-467-2824